FENNEC PHARMACEUTICALS INC (FRX.CA) Stock News

Canada - TSX:FRX - CA31447P1009 - Common Stock

11.59 CAD

-0.65 (-5.31%)

Last: 10/17/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FRX.CA Latest News, Press Relases and Analysis

All

Press Releases

2 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update

2 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025

5 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Announces Results of Annual Meeting

5 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

6 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

8 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Announces Results of Annual Meeting

8 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025

9 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

10 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

10 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management

10 months ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Announces Management Change

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

a year ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Announces Incremental $5 Million Investment from Petrichor

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Announces Results of Annual Meeting

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

2 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023

3 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients

3 years ago - By: Fennec Pharmaceuticals Inc. - Mentions: FENC

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results